on Financial Conduct Authority
Roquefort Therapeutics plc Delisted from Official List
The Financial Conduct Authority (FCA) has removed Roquefort Therapeutics plc's securities from the Official List as of March 27, 2026, at 08:00 GMT. The delisted securities include ordinary shares of 1p each, fully paid, under the ISIN code GB00BMDQ2T15. This action signifies a significant regulatory change affecting the company's presence on the market.
The ordinary shares were previously part of the equity shares category (transition) on the London Stock Exchange, an acknowledged investment platform. Investors and stakeholders are informed to take note of this change, which could impact trading perceptions and strategies related to Roquefort Therapeutics plc.
This notice has been disseminated by Listings Data Management and underlines the crucial need for investors to stay updated with official announcements from recognised investment exchanges and the FCA regarding securities admissions and removals.
R. P.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Financial Conduct Authority news